We recently published a list of Cathie Wood’s Top 12 AI Stock Picks in 2025. In this article, we are going to take a look at ...

We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Tempus ...

Tempus AI, Inc. TEM recently announced the acquisition of Deep 6 AI, a leading artificial intelligence (AI) company ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

has been to expand a partnership with Tempus aimed at improving the big pharma's R&D productivity, starting with its cancer pipeline. US-based Tempus has built a precision medicine platform ...

Tempus AI seeks to make medicine smarter. At its core, it collects and analyzes genetic and clinical data to help doctors make better treatment decisions, especially for cancer. They are trying to ...

On February 21, Tempus AI, Inc. (NASDAQ:TEM) partnered with Menarini Group and its subsidiary, Stemline Therapeutics, to improve metastatic breast cancer care using its AI-powered Next platform.

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

Tempus AI extended its winning streak for a ... which includes academic medical centers, National Cancer Institute (NCI)-Designated Cancer Centers, and NCI Community Oncology Research Programs.

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ ... which includes academic medical centers, National Cancer Institute (NCI)-Designated Cancer Centers, and NCI Community Oncology Research ...

Tempus AI, Inc. TEM recently announced the acquisition of Deep 6 AI, a leading artificial intelligence (AI) company specializing in clinical trial matching. This strategic move aims to enhance ...